Loading…
MicroPort CardioFlow Medtech Corporation will acquire MicroPort Cardiac Rhythm Management through a non-cash transaction issuing new shares with a total consideration of USD 680 million, approved by shareholders on December 15, 2025.
CardioFlow (02160) announced a merger agreement to acquire MicroPort Cardiac Rhythm Management (a subsidiary of MicroPort Scientific) for a valuation of $680 million. The acquisition will be effected through a merger, with CardioFlow issuing new shares as consideration.